314 related articles for article (PubMed ID: 7658708)
1. Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations.
Litz CE; Davies S; Brunning RD; Kueck B; Parkin JL; Gajl Peczalska K; Arthur DC
Leukemia; 1995 Sep; 9(9):1432-9. PubMed ID: 7658708
[TBL] [Abstract][Full Text] [Related]
2. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
[TBL] [Abstract][Full Text] [Related]
3. Acute leukemias in children with Down syndrome.
Zwaan MC; Reinhardt D; Hitzler J; Vyas P
Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
5. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
7. The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations.
Forestier E; Schmiegelow K;
J Pediatr Hematol Oncol; 2006 Aug; 28(8):486-95. PubMed ID: 16912588
[TBL] [Abstract][Full Text] [Related]
8. Acute leukemias in children with Down syndrome.
Zwaan CM; Reinhardt D; Hitzler J; Vyas P
Hematol Oncol Clin North Am; 2010 Feb; 24(1):19-34. PubMed ID: 20113894
[TBL] [Abstract][Full Text] [Related]
9. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
10. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
11. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
[TBL] [Abstract][Full Text] [Related]
12. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
13. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
15. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
Lundin C; Hjorth L; Behrendtz M; Nordgren A; Palmqvist L; Andersen MK; Biloglav A; Forestier E; Paulsson K; Johansson B
Genes Chromosomes Cancer; 2012 Feb; 51(2):196-206. PubMed ID: 22072402
[TBL] [Abstract][Full Text] [Related]
16. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
17. [Transient abnormal myelopoiesis followed by acute leukemia in children with Down syndrome].
Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
Rinsho Ketsueki; 1990 Dec; 31(12):1939-44. PubMed ID: 2150419
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic findings in acute biphenotypic leukaemia.
Carbonell F; Swansbury J; Min T; Matutes E; Farahat N; Buccheri V; Morilla R; Secker-Walker L; Catovsky D
Leukemia; 1996 Aug; 10(8):1283-7. PubMed ID: 8709632
[TBL] [Abstract][Full Text] [Related]
19. [The immunophenotypic and cytogenetic characteristics of the blast cells in subvariants of acute myeloid leukemia].
Isakova LM; Tretiak NN; Khromiak VN; Gordienko AI; Zverkova AS; Vakul'chuk AM
Tsitol Genet; 2000; 34(1):48-56. PubMed ID: 10808542
[TBL] [Abstract][Full Text] [Related]
20. B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome.
Lundin C; Heldrup J; Ahlgren T; Olofsson T; Johansson B
Eur J Haematol; 2009 Jan; 82(1):46-53. PubMed ID: 19067745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
